6MSS image
Entry Detail
PDB ID:
6MSS
Keywords:
Title:
Diversity in the type II Natural Killer T cell receptor repertoire and antigen specificity leads to differing CD1d docking strategies
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2018-10-18
Release Date:
2019-10-02
Method Details:
Experimental Method:
Resolution:
3.00 Å
R-Value Free:
0.24
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:A11B8.2 NKT TCR alpha-chain
Chain IDs:A
Chain Length:203
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:A11B8.2 NKT TCR beta-chain
Chain IDs:B
Chain Length:245
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:Antigen-presenting glycoprotein CD1d1
Chain IDs:C
Chain Length:302
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:Beta-2-microglobulin
Chain IDs:D
Chain Length:99
Number of Molecules:1
Biological Source:Mus musculus
Primary Citation
Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.
Nat Commun 10 5242 5242 (2019)
PMID: 31748533 DOI: 10.1038/s41467-019-12941-9

Abstact

Type I and type II natural killer T (NKT) cells are restricted to the lipid antigen-presenting molecule CD1d. While we have an understanding of the antigen reactivity and function of type I NKT cells, our knowledge of type II NKT cells in health and disease remains unclear. Here we describe a population of type II NKT cells that recognise and respond to the microbial antigen, α-glucuronosyl-diacylglycerol (α-GlcADAG) presented by CD1d, but not the prototypical type I NKT cell agonist, α-galactosylceramide. Surprisingly, the crystal structure of a type II NKT TCR-CD1d-α-GlcADAG complex reveals a CD1d F'-pocket-docking mode that contrasts sharply with the previously determined A'-roof positioning of a sulfatide-reactive type II NKT TCR. Our data also suggest that diverse type II NKT TCRs directed against distinct microbial or mammalian lipid antigens adopt multiple recognition strategies on CD1d, thereby maximising the potential for type II NKT cells to detect different lipid antigens.

Legend

Protein

Chemical

Disease

Primary Citation of related structures